C

Corcept Therapeutics

develops cortisol-modulating therapies for Cushing's syndrome

Manager – Internal Events and Community

Creative ProductionConfirmed live in the last 24 hours
Full-timeRedwood City, CA, USA$150.7k - $177.3k

About the Job

Requirements

  • Strong organizational and project management skills with exceptional attention to detail.
  • Experience managing multiple events, timelines, vendors, and priorities simultaneously.
  • Strong interpersonal and communication skills to work effectively with employees at all levels.
  • A positive, solutions-oriented attitude and willingness to help wherever needed.
  • Ability to lift 25 pounds.

Responsibilities

  • Plan, coordinate, and execute onsite employee and corporate events, including department-wide meetings, corporate meetings and special events, employee engagement activities, food truck events and catered experiences, fundraising events, walks and runs, and volunteer programs.
  • Manage event execution, including timelines, budgets, venue and space planning, catering, vendors, audiovisual needs, signage, décor, registration, transportation, and other event logistics.
  • Serve as the primary onsite point of contact during events, proactively resolving issues and adapting to changing circumstances to ensure a seamless experience.
  • Coordinate event setup and breakdown, including moving tables, chairs, signage, supplies, and other event materials as needed.

Desired Qualifications

  • At least 5 years of professional event management experience, preferably managing corporate, employee, or large-scale events.
  • Experience in the biotechnology or pharmaceutical industry.

About the Company

Corcept Therapeutics

develops cortisol-modulating therapies for Cushing's syndrome

Corcept Therapeutics develops and commercializes cortisol modulators to treat disorders caused by abnormal cortisol levels. Its core product, Korlym (mifepristone), blocks cortisol’s action by acting as a cortisol receptor antagonist and is approved for hypercortisolism in Cushing’s syndrome. The company differentiates itself with a dedicated focus on cortisol modulation, an extensive pipeline of proprietary molecules, and ongoing development beyond Korlym. Its goal is to improve outcomes for patients with cortisol-related disorders by expanding access to effective therapies and advancing new treatments.

Company size
501-1,000
Company stage
IPO
Headquarters
Menlo Park, CA
Founded
1998

Recently Posted Jobs

Explore more opportunities at Corcept Therapeutics

See more jobs